Answers are grounded in this paper and cite their sources.
PURPOSE: Exposure to high doses of ionizing radiation may cause acute radiation syndrome (ARS), in which reactive oxygen and carbonyl species (ROS/RCS) and DNA damage contribute to cell death and depletion of bone marrow and peripheral blood cells. Although recombinant growth factor therapies reduce mortality in preclinical models, their reliance on parenteral administration may limit their utility in mass-casualty scenarios. Imidazolyl ethanamide pentandioic acid (IEPA) is an orally bioavailable small molecule that improves survival in rodent models of ARS. While in vitro data suggest an antioxidant mechanism, its mode of action in vivo remains incompletely understood. MATERIALS AND METHODS: Mechanistic studies were conducted in female WAG/RijCmcr rats exposed to 7.75 Gy total-body irradiation (TBI). Systemic oxidative stress was assessed by quantifying reduced glutathione levels in blood. Urine from IEPA-treated animals was analyzed by LC-MS/MS for metabolites indicative of RCS scavenging. Protein carbonylation was evaluated in vitro by Western blot. Transcriptomic alterations associated with IEPA treatment were characterized by RNA sequencing (RNA-seq) of bone marrow and peripheral blood samples collected on days 4 and 14 post-TBI. RESULTS: IEPA increased reduced glutathione levels in the blood of irradiated rats by 21% (p = .035). A product of the direct scavenging reaction between IEPA and the prevalent RCS 4-hydroxynonenal (4-HNE) was detected in urine. IEPA reduced 4-HNE-mediated protein carbonylation in vitro. In addition, IEPA treatment was associated with transcriptomic changes (132 differentially expressed genes with fold change > 2, p.adj < 0.05) particularly in the peripheral blood on day 14 post-TBI. Gene ontology analysis indicated modulation of immune cell differentiation. CONCLUSIONS: IEPA attenuated irradiation-induced systemic oxidative stress, potentially in part through direct scavenging of RCS. Associated transcriptomic changes suggest modulation of immune differentiation pathways in peripheral blood. This warrants further study of RCS scavenging, oxidative stress reduction and immunomodulation in IEPA treatment in the future.
No takes yet. Share an insight, caveat, or question.
Eibl et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: